KLK3 and posterior cortical atrophy: In addition to PSA contamination in the control arm and potential overdiagnosis associated with screening, potential missed PCa under traditional screening strategy and low proportion of clinically significant PCa among screening-detected PCa would be another key explanations for the lack of a reduction in mortality observed in both PLCO and CAP [5, 8–12].